Syndax’s leadership in menin inhibition and CSF-1R inhibition – – Revumenib abstracts showcase compelling results in multiple acute leukemia subtypes across the R/R, frontline, and post-HSCT setting – ...
Terns Pharmaceuticals ( ($TERN) ) has shared an announcement. On November 3, 2025, Terns Pharmaceuticals announced that data from the Phase 1 ...
Leaders don’t need more slides—they need more sensemaking. The future of presentations is clarity, story, and presence, not ...
Perspective Therapeutics announced data presentations at ASCO 2025 for its cancer treatment programs [212Pb]VMT-α-NET and [212Pb]VMT01. Perspective Therapeutics, Inc. announced that it will present ...
Keeping up with technology can be difficult for many people as artificial intelligence is a relatively new tool that has ...
Several dozen people attended a recent presentation on the "Impact of the Data Center Boom on Virginia Communities" sponsored by a newly formed group called Winchester-area Interfaith ...
Pharmaceuticals announced that 23 abstracts, including six oral presentations, showcasing compelling Revuforj and Niktimvo data were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback